Literature DB >> 29427473

Antimicrobial and cytotoxic activity of silver nanoparticles synthesized from two haloalkaliphilic actinobacterial strains alone and in combination with antibiotics.

M Wypij1, M Świecimska1, J Czarnecka2, H Dahm1, M Rai3, P Golinska1.   

Abstract

AIMS: Presently, the effective antimicrobial agents have been limited by the emergence of microbial strains with multidrug resistance and biofilm formation potential. In the present study, we report remarkable antimicrobial activity of silver nanoparticles (AgNPs) synthesized from Streptomyces calidiresistens IF11 and IF17 strains, including inhibition of biofilm formation and synergistic effect of AgNPs and antibiotics against selected bacteria and yeasts. Cytotoxic effect of AgNPs on mammalian cell lines was also evaluated. METHODS AND
RESULTS: Analysis of biosynthesized AgNPs by Fourier Transform Infrared Spectroscopy and transmission electron microscopy revealed their spherical shape, small size in the range of 5-50 and 5-20 nm, respectively, as well as the presence of capping agents. Study of antimicrobial activity of AgNPs against Bacillus subtilis, Staphylococcus aureus, Escherichia coli, Candida albicans and Malassezia furfur evaluated by minimum inhibitory concentration (MIC) and minimum biocidal concentration (MBC) assays revealed that MICs of AgNPs from IF11 and IF17 strains against bacteria and yeasts were found to be in the range of 16-128 and 8-256 μg ml-1 , while MBCs were in the range of 48-192 and 32-256 μg ml-1 respectively. AgNPs inhibited biofilm formation of microbial strains, which was tested by using crystal violet stain. The highest synergistic effect determined by fractional inhibitory index of AgNPs with antibiotic (kanamycin or tetracycline) was found against Staph. aureus; while in case of yeasts, M. furfur showed highest sensitivity to AgNPs-ketoconazole combination (FIC = 0·12). The cytotoxic activity of AgNPs towards HeLa and 3T3 cell lines was studied by MTT assay. The IC50 of AgNPs estimated against mouse fibroblasts was found to be 8·3 and 28·3 μg ml-1 and, against HeLa cell line, 28·5 and 53·8 μg ml-1 respectively.
CONCLUSIONS: It can be concluded that AgNPs synthesized from S. calidiresistens IF11 and IF17 strains have potential as an effective antimicrobial and cytotoxic agent, especially when used in combination with antibiotics/antifungal agents. SIGNIFICANCE AND IMPACT OF THE STUDY: This study indicates potential application of biogenic silver nanoparticles as an antimicrobial agent in nanomedicine.
© 2018 The Society for Applied Microbiology.

Entities:  

Keywords:  zzm321990Streptomyceszzm321990; antimicrobials; biofilm; cytotoxicity; haloalkaliphiles; nanotechnology

Mesh:

Substances:

Year:  2018        PMID: 29427473     DOI: 10.1111/jam.13723

Source DB:  PubMed          Journal:  J Appl Microbiol        ISSN: 1364-5072            Impact factor:   3.772


  4 in total

1.  Green Synthesized Silver Nanoparticles: Antibacterial and Anticancer Activities, Biocompatibility, and Analyses of Surface-Attached Proteins.

Authors:  Magdalena Wypij; Tomasz Jędrzejewski; Joanna Trzcińska-Wencel; Maciej Ostrowski; Mahendra Rai; Patrycja Golińska
Journal:  Front Microbiol       Date:  2021-04-22       Impact factor: 5.640

2.  Biogenic Silver Nanoparticles: Assessment of Their Cytotoxicity, Genotoxicity and Study of Capping Proteins.

Authors:  Magdalena Wypij; Tomasz Jędrzejewski; Maciej Ostrowski; Joanna Trzcińska; Mahendra Rai; Patrycja Golińska
Journal:  Molecules       Date:  2020-07-02       Impact factor: 4.411

Review 3.  Marine Actinomycetes, New Sources of Biotechnological Products.

Authors:  Sveta V Jagannathan; Erika M Manemann; Sarah E Rowe; Maiya C Callender; William Soto
Journal:  Mar Drugs       Date:  2021-06-25       Impact factor: 5.118

4.  Evaluation of Zebrafish DNA Integrity after Individual and Combined Exposure to TiO2 Nanoparticles and Lincomycin.

Authors:  Filomena Mottola; Concetta Iovine; Marianna Santonastaso; Vincenzo Carfora; Severina Pacifico; Lucia Rocco
Journal:  Toxics       Date:  2022-03-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.